BRÈVE

sur AMOEBA (EPA:ALMIB)

Amoéba's AXPERA Solution Wins SIVAL d'Or Award

Graphique de l'évolution du cours de l'action AMOEBA (EPA:ALMIB).

Amoéba, a greentech firm specializing in natural microbiological solutions, has been awarded the Gold Medal at the SIVAL Innovation 2026 for its AXPERA biocontrol solution. This recognition, following the Bernard Blum Gold Award, highlights the efficacy of Amazon's unique amoeba lysate technology against parasitic fungi. The award underscores its commercial potential, appreciated by professionals in various plant sectors.

The SIVAL Innovation Competition, held at the International Plant Production Techniques Exhibition, honored the AXPERA solution for its sustainable approach to combating fungal diseases. This solution offers a credible alternative to copper-based products, especially for vine downy mildew control. AXPERA's advancements come as French regulations on copper use tighten.

Aligning with regulatory milestones, Amoéba has obtained approval in the US and awaits European and Brazilian decisions. The company continues to expand its global reach, providing sustainable solutions to the agricultural industry.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AMOEBA